Compass Therapeutics (CMPX) Current Taxes (2019)

Compass Therapeutics (CMPX) reported Current Taxes of $554000.0 for Q4 2019.

Compass Therapeutics (CMPX) Current Taxes (2019) Analysis & Trends

Compass Therapeutics (CMPX) has 1 years of Current Taxes data on file, last reported at $554000.0 in Q4 2019.

  • For the quarter ending Q4 2019, Current Taxes changed N/A year-over-year to $554000.0; the trailing twelve-month figure through Dec 2019 stood at $554000.0 (changed N/A YoY), and the FY2019 full-year result was $554000.0, changed N/A from the prior year.
  • Current Taxes held at $554000.0 in Q4 2019.
  • In the past five years, Current Taxes ranged from a high of $554000.0 in Q4 2019 to a low of $554000.0 in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 63.52 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 49.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Compass Therapeutics 395.17 Mn 200.48 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2019 554,000.00